At Capnia, which is a subsidiary of Soleno, we are developing and commercializing innovative diagnostics, devices, and therapeutic products designed to help the smallest patients overcome their biggest obstacles.

Capnia has developed the CoSense® End-Tidal Carbon Monoxide Monitor that measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. Non-invasive hemolysis detection has important applications for the neonatology market, and newborn care will be an initial commercial focus for the product.

Capnia Products – Soleno